Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1991;17:776-779

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Escalante, B.
Right arrow Articles by McGiff, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Escalante, B.
Right arrow Articles by McGiff, J. C.

Hypertension, Vol 17, 776-779, Copyright © 1991 by American Heart Association


ARTICLES

Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats

B Escalante, D Sacerdoti, MM Davidian, M Laniado-Schwartzman and JC McGiff
Department of Pharmacology, New York Medical College, Valhalla 10595.

We have reported that short-term treatment of spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats with stannous chloride (SnCl2), which selectively depletes renal cytochrome P450, restores blood pressure to normal in young but not in adult SHR, and is without effect on blood pressure of either young or adult WKY rats. We report in the present study that chronic treatment with SnCl2, begun at age 5 weeks, prevented the development of hypertension in SHR over a period of 15 weeks at which time they were killed. Suspension of SnCl2 treatment after 8 weeks (i.e., at age 13 weeks) did not result in return of blood pressure to hypertensive levels in SHR. Age-matched WKY rats were not affected by tin treatment. These findings provide additional evidence that administration of tin, which stimulates heme oxygenase, thereby producing depletion of cytochrome P450, restores blood pressure to normal levels in SHR.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
H. Zhao, R. J. Wong, T. C. Doyle, N. Nayak, H. J. Vreman, C. H. Contag, and D. K. Stevenson
Regulation of Maternal and Fetal Hemodynamics by Heme Oxygenase in Mice
Biol Reprod, April 1, 2008; 78(4): 744 - 751.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Vargas, J. M. Moreno, R. Wangensteen, I. Rodriguez-Gomez, and J. Garcia-Estan
The endocrine system in chronic nitric oxide deficiency
Eur. J. Endocrinol., January 1, 2007; 156(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Wang, R. Shamloul, X. Wang, Q. Meng, and L. Wu
Sustained Normalization of High Blood Pressure in Spontaneously Hypertensive Rats by Implanted Hemin Pump
Hypertension, October 1, 2006; 48(4): 685 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W.-C. Lo, P.-J. Lu, W.-Y. Ho, M. Hsiao, and C.-J. Tseng
Induction of Heme Oxygenase-1 Is Involved in Carbon Monoxide-Mediated Central Cardiovascular Regulation
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. R. Harder and R. J. Roman
Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus
Circ. Res., April 14, 2006; 98(7): 866 - 867.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Wu and R. Wang
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman
Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor
Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Physiol Rev, April 1, 2005; 85(2): 679 - 715.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-H. Chen, S.-F. Yet, and M. A. Perrella
Role of Heme Oxygenase-1 in the Regulation of Blood Pressure and Cardiac Function
Experimental Biology and Medicine, May 1, 2003; 228(5): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. Ndisang, W. Zhao, and R. Wang
Selective Regulation of Blood Pressure by Heme Oxygenase-1 in Hypertension
Hypertension, September 1, 2002; 40(3): 315 - 321.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. M. Hoagland, K. G. Maier, C. Moreno, M. Yu, and R. J. Roman
Cytochrome P450 metabolites of arachidonic acid: novel regulators of renal function
Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2283 - 2285.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. GROSS, W. SCHNEIDER, W.-H. SCHUNCK, E. MERVAALA, and F. C. LUFT
Chronic Effects of Lovastatin and Bezafibrate on Cortical and Medullary Hemodynamics in Deoxycorticosterone Acetate-Salt Hypertensive Mice
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1430 - 1439.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. O. Oyekan, K. McAward, J. Conetta, L. Rosenfeld, and J. C. McGiff
Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R766 - R775.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Fulton, J. R. Falck, J. C. McGiff, M. A. Carroll, and J. Quilley
A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol
J. Lipid Res., August 1, 1998; 39(8): 1713 - 1721.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Ishizaka and K. K. Griendling
Heme Oxygenase-1 Is Regulated by Angiotensin II in Rat Vascular Smooth Muscle Cells
Hypertension, March 1, 1997; 29(3): 790 - 795.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. E. Stec, M. R. Trolliet, J. E. Krieger, H. J. Jacob, and R. J. Roman
Renal Cytochrome P4504A Activity and Salt Sensitivity in Spontaneously Hypertensive Rats
Hypertension, June 1, 1996; 27(6): 1329 - 1336.
[Abstract] [Full Text]